Rising Demand for Real-Time Situational Awareness, Lightweight Sensor-Based Helmets, and Advanced Augmented Reality Systems Accelerating Global Military HMD Adoption.Austin, United States, March 10, ...
ReVision now anticipates initiating early-stage human clinical trials of its Occular BCI in blind volunteers in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results